This Midcap Pharma Stock Reaches 52 Week Low, Set To Supply Covid Vaccines To Children, Share Fall 17% In 1 Yr

The stock price of Pfizer Ltd. has reached its 52 weeks low-level today in the initial trading hours. The share price of Orient Cement Ltd. stood at Rs. 4,117.40, today 12.24pm.

Pfizer Ltd. - NSE market tracking

It is a midcap company with a market capitalization of Rs. 18,779 crore. The 52 week high level of this stock is Rs. 6,175, and 52 week low level of this stock is Rs. 4,070. In the past 6 months, its stock price has fallen by 17.53%, in the past 1 year its stock price has fallen by 24.97%. However, in the past 2 years the stock's price has gained marginally, as the Indian stock market is bearish now. However, if you are looking forward to a long term investment this pharma stock can be a good pick. On NSE, its share price has gained by around 132%.

The company is also fetching a dividend yield of 0.85%, which can be profitable for investors. Recently, the FDA has recommended and approved Covid-19 vaccinations from Pfizer along with some other pharma manufacturers for millions of children in the US. The FDA will be authorizing the shots in the near future, which can be another push for the company's stock prices along with financial developments. soon.

According to data available with NSE, in Q4 FY22, Pfizer's Total Income stood at Rs. 54,966 lakh, as against Rs. 67,590 lakh in the previous quarter. The company's Profit before tax (PBT) was reported at Rs. 14,511 lakh, as against Rs. 18,409 lakh in Q3 FY22. Additionally, its Net Profit stood at Rs. 12,579 lakh, as against Rs. 14,391 lakh in the earlier quarter.

The company was founded in 1849. the company's every product is the result of 1,500 scientists overseeing more than 500,000 lab tests and 30+ clinical trials, all before its first prescription.